These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7570647)

  • 1. ATSDR's information databases to support human health risk assessment of hazardous substances. Agency for Toxic Substances and Disease Registry.
    Johnson BL
    Toxicol Lett; 1995 Sep; 79(1-3):11-6. PubMed ID: 7570647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Great lakes research--important human health findings and their impact on ATSDR's Superfund research program.
    Hicks HE; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):49-61. PubMed ID: 12018016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Findings and accomplishments of ATSDR's Superfund-mandated Substance-Specific Applied Research Program.
    Stevens YW; Williams-Johnson MM; De Rosa CT; Cibulas W
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):29-39. PubMed ID: 12018014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating toxicologic end points to derive minimal risk levels for hazardous substances.
    Chou CH; Williams M; Jones D; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):71-5. PubMed ID: 12018018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions of environmental public health research: ATSDR's 2002-2010 agenda for six priority focus areas.
    Spengler RF; Falk H
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):77-83. PubMed ID: 12018019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The toxicologic hazard of superfund hazardous-waste sites.
    Johnson BL; DeRosa C
    Rev Environ Health; 1997; 12(4):235-51. PubMed ID: 9553998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision support methodologies for human health assessment of toxic substances: Agency for Toxic Substances and Disease Registry's perspectives on collaboration and infrastructure development among government, academia, and industry.
    DeRosa CT
    Toxicol Lett; 1995 Sep; 79(1-3):283-5. PubMed ID: 7570665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving with the times, the new national toxic substance incidents program.
    Duncan MA; Orr MF
    J Med Toxicol; 2010 Dec; 6(4):461-3. PubMed ID: 20838954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agency for Toxic Substances and Disease Registry Brownfields/ land-reuse site tool.
    Perlman GD; Berman L; Leann K; Bing L
    J Environ Health; 2012 Dec; 75(5):30-4. PubMed ID: 23270111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing risk communication effectiveness: perspectives of agency practitioners.
    Tinker TL; Collins CM; King HS; Hoover MD
    J Hazard Mater; 2000 Apr; 73(2):117-27. PubMed ID: 10708888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergency response program at the Agency for Toxic Substances and Disease Registry.
    Holler J
    J Environ Health; 2013 Oct; 76(3):46-7. PubMed ID: 24288850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for emergency events involving hazardous substances--United States, 1990-1992.
    Hall HI; Dhara VR; Price-Green PA; Kaye WE
    MMWR CDC Surveill Summ; 1994 Jul; 43(2):1-6. PubMed ID: 8035774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of hazardous substance emergency events: identifying areas for public health prevention.
    Kaye WE; Orr MF; Wattigney WA
    Int J Hyg Environ Health; 2005; 208(1-2):37-44. PubMed ID: 15881977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer policy framework for: public health assessment of carcinogens in the environment.
    DeRosa CT; Stevens YW; Johnson BL
    Toxicol Ind Health; 1993; 9(4):559-75. PubMed ID: 8296311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hazardous-chemical releases in the home.
    Ruckart PZ; Orr MF; Kaye WE
    J Environ Health; 2004 Dec; 67(5):14-9, 32; quiz 35-6. PubMed ID: 15628191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a priority list of chemical mixtures occurring at 1188 hazardous waste sites, using the HazDat database.
    Fay RM; Mumtaz MM
    Food Chem Toxicol; 1996; 34(11-12):1163-5. PubMed ID: 9119332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health guidance values for chemical mixtures: current practice and future directions.
    Pohl HR; Hansen H; Chou CH
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):322-9. PubMed ID: 9441922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing uncertainty factors in minimal risk levels derivation.
    Pohl HR; Abadin HG
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):180-8. PubMed ID: 8577953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of acute exposure guideline levels for hazardous substances.
    Rusch GM; Garrett R; Tobin P; Falke E; Lu PY
    Drug Chem Toxicol; 2002 Nov; 25(4):339-48. PubMed ID: 12378946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.